CAD 0.32
(6.67%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 151.74 Million USD | -35.05% |
2022 | 233.62 Million USD | 7.76% |
2021 | 216.8 Million USD | 44.54% |
2020 | 150 Million USD | 138.48% |
2019 | 62.89 Million USD | 39.94% |
2018 | 44.94 Million USD | 486.98% |
2017 | 7.65 Million USD | 487581.15% |
2016 | 1570.09 USD | -4.09% |
2015 | 1637.06 USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 242.43 Million USD | 54.04% |
2024 Q1 | 157.38 Million USD | 3.72% |
2023 Q2 | 222.7 Million USD | -1.99% |
2023 FY | 151.74 Million USD | -35.05% |
2023 Q3 | 178.37 Million USD | -19.9% |
2023 Q4 | 151.74 Million USD | -14.93% |
2023 Q1 | 227.22 Million USD | -2.74% |
2022 Q3 | 263.41 Million USD | -1.87% |
2022 Q4 | 233.62 Million USD | -11.31% |
2022 Q2 | 268.44 Million USD | -2.03% |
2022 FY | 233.62 Million USD | 7.76% |
2022 Q1 | 273.99 Million USD | 26.38% |
2021 Q1 | 218.44 Million USD | 45.63% |
2021 Q4 | 216.8 Million USD | -1.68% |
2021 FY | 216.8 Million USD | 44.54% |
2021 Q2 | 226.22 Million USD | 3.57% |
2021 Q3 | 220.51 Million USD | -2.53% |
2020 Q1 | 66.52 Million USD | 5.76% |
2020 FY | 150 Million USD | 138.48% |
2020 Q2 | 81.46 Million USD | 22.47% |
2020 Q3 | 125.47 Million USD | 54.02% |
2020 Q4 | 150 Million USD | 19.55% |
2019 Q4 | 62.89 Million USD | -6.29% |
2019 Q1 | 55.51 Million USD | 23.51% |
2019 FY | 62.89 Million USD | 39.94% |
2019 Q2 | 62.87 Million USD | 13.26% |
2019 Q3 | 67.11 Million USD | 6.75% |
2018 Q2 | 26.94 Million USD | 12664.5% |
2018 FY | 44.94 Million USD | 486.98% |
2018 Q4 | 44.94 Million USD | 67.36% |
2018 Q3 | 26.85 Million USD | -0.33% |
2018 Q1 | 211.07 Thousand USD | 13278.43% |
2017 Q3 | 1638.82 USD | 4.38% |
2017 Q4 | 1577.73 USD | -3.73% |
2017 FY | 7.65 Million USD | 487581.15% |
2017 Q2 | 1570.09 USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 FY | 1570.09 USD | -4.09% |
2015 FY | 1637.06 USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aion Therapeutic Inc. | 210.67 Thousand CAD | -71929.857% |
Ayurcann Holdings Corp. | 14.85 Million CAD | -921.597% |
Blueberries Medical Corp. | 2.41 Million CAD | -6179.182% |
The BC Bud Corporation | 632.06 Thousand CAD | -23908.053% |
BioNxt Solutions Inc. | 1.26 Million CAD | -11871.591% |
CordovaCann Corp. | 10.26 Million CAD | -1378.479% |
Christina Lake Cannabis Corp. | 15.96 Million CAD | -850.644% |
Captor Capital Corp. | 33.85 Million CAD | -348.232% |
City View Green Holdings Inc. | 3846.00 CAD | -3945473.089% |
1CM Inc. | 34.01 Million CAD | -346.068% |
Global Hemp Group Inc. | 42.76 Thousand CAD | -354771.825% |
Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | -358.6% |
IM Cannabis Corp. | 48.81 Million CAD | -210.874% |
Lobe Sciences Ltd. | 2.29 Million CAD | -6499.145% |
Maple Leaf Green World Inc. | 168.27 Thousand CAD | -90078.9% |
Mountain Valley MD Holdings Inc. | 8.96 Million CAD | -1592.469% |
Nextleaf Solutions Ltd. | 8.53 Million CAD | -1677.511% |
Ovation Science Inc. | 76.88 Thousand CAD | -197260.76% |
Pharmadrug Inc. | 1.45 Million CAD | -10295.848% |
Captiva Verde Wellness Corp. | 9.1 Million CAD | -1567.126% |
RAMM Pharma Corp. | 32.3 Million CAD | -369.798% |
RIV Capital Inc. | 1.74 Million CAD | -8618.311% |
Revive Therapeutics Ltd. | 10.63 Million CAD | -1326.74% |
Red White & Bloom Brands Inc. | 234.25 Million CAD | 35.221% |
SLANG Worldwide Inc. | 33.2 Million CAD | -357.026% |
1933 Industries Inc. | 18.01 Million CAD | -742.114% |
Red Light Holland Corp. | 24.08 Million CAD | -530.074% |
Top Strike Resources Corp. | 11.73 Million CAD | -1193.09% |
Xebra Brands Ltd. | 379.36 Thousand CAD | -39899.879% |
Adastra Holdings Ltd. | 32.34 Million CAD | -369.183% |